Sastasundar Ventures Ltd
NSE:SASTASUNDR
Intrinsic Value
Sastasundar Ventures Ltd. distributes health care and pharmaceutical products. [ Read More ]
The intrinsic value of one
SASTASUNDR
stock under the Base Case scenario is
178.05
INR.
Compared to the current market price of 303 INR,
Sastasundar Ventures Ltd
is
Overvalued by 41%.
Sastasundar Ventures Ltd's market capitalization is 9.6B INR.
SASTASUNDR stock price is 303 INR.
SASTASUNDR stock (178.05 INR) is 41% less than its price (303 INR).
SASTASUNDR stock (2.76 INR) is 99% less than its price (303 INR). Open DCF Valuation
SASTASUNDR stock price (303 INR) is 14% less than its Relative Value (353.33 INR). Open Relative Valuation
SASTASUNDR has upside potential of 101% compared to the average analyst price target.
Open Wall St Estimates
SASTASUNDR's ROE (Return on Equity) has increased in the last 3 years from -5% to -4%, and is approaching profitability.
SASTASUNDR has negative Operating Income for the last twelve months.
SASTASUNDR has positive Gross Profit for the last twelve months.
SASTASUNDR's ROIC (Return on Invested Capital) has increased in the last 3 years from -8% to -1%, and is approaching profitability.
SASTASUNDR has positive three-year average ROIC (Return on Invested Capital): 6%. The company is efficient at using invested capital to generate operating income.
SASTASUNDR's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -1%.
SASTASUNDR has negative Net Debt. This means that the company has more cash and short-term investments (104m INR) than debt (87m INR).
SASTASUNDR's ROE (Return on Equity) for the past 12 months is negative and is equal to -4%.
SASTASUNDR's Revenue has grown by an exceptional 56% over the past 12 months.
SASTASUNDR has negative Net Income for the last twelve months.
SASTASUNDR's short-term assets (2B INR) exceed its short-term liabilties (932m INR).
SASTASUNDR's Revenue has been growing by an exceptional 38% per year for the last 3 years.
SASTASUNDR's long-term assets (12B INR) exceed its long-term liabilties (4B INR).
SASTASUNDR has negative Free Cash Flow for the last twelve months.
SASTASUNDR's Altman Z-Score is very high and is equal to 3.87.
SASTASUNDR's D/E (Debt to Equity) is very low and is equal to 0.01.
SASTASUNDR has very high three-year average ROE (Return on Equity): 52%. The company is very efficient at transforming stockholders' equity into net income.
SASTASUNDR doesn't generate enough operating income (-46m INR) to safely cover interest payments on its debt (10m INR).
Valuation Backtest
Sastasundar Ventures Ltd
Run backtest to discover the historical profit from buying and selling
SASTASUNDR
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Sastasundar Ventures Ltd
Balance Sheet Decomposition
Sastasundar Ventures Ltd
| Current Assets | 2.1B |
| Cash & Short-Term Investments | 103.7m |
| Receivables | 403.1m |
| Other Current Assets | 1.6B |
| Non-Current Assets | 9.8B |
| Long-Term Investments | 5.2B |
| PP&E | 676.5m |
| Intangibles | 362.2m |
| Other Non-Current Assets | 3.5B |
| Current Liabilities | 932.2m |
| Accounts Payable | 662.8m |
| Other Current Liabilities | 269.3m |
| Non-Current Liabilities | 3.5B |
| Long-Term Debt | 87.4m |
| Other Non-Current Liabilities | 3.4B |
Earnings Waterfall
Sastasundar Ventures Ltd
|
Revenue
|
13.8B
INR
|
|
Cost of Revenue
|
-12.4B
INR
|
|
Gross Profit
|
1.4B
INR
|
|
Operating Expenses
|
-1.5B
INR
|
|
Operating Income
|
-45.7m
INR
|
|
Other Expenses
|
-270m
INR
|
|
Net Income
|
-315.7m
INR
|
Free Cash Flow Analysis
Sastasundar Ventures Ltd
SASTASUNDR Profitability Score
Profitability Due Diligence
Sastasundar Ventures Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Sastasundar Ventures Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
SASTASUNDR Solvency Score
Solvency Due Diligence
Sastasundar Ventures Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Sastasundar Ventures Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SASTASUNDR Price Targets Summary
Sastasundar Ventures Ltd
According to Wall Street analysts, the average 1-year price target for
SASTASUNDR
is 607.92 INR
with a low forecast of 601.96 INR and a high forecast of 625.8 INR.
Shareholder Return
SASTASUNDR Price
Sastasundar Ventures Ltd
| Average Annual Return | 67.27% |
| Standard Deviation of Annual Returns | 142.88% |
| Max Drawdown | -64% |
| Market Capitalization | 9.6B INR |
| Shares Outstanding | 31 810 500 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Sastasundar Ventures Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Sastasundar Ventures Ltd. distributes health care and pharmaceutical products. The company is headquartered in Kolkata, West Bengal. The company went IPO on 2010-10-05. The firm's segments include Financial Services and Healthcare Network. The Financial Services segment consists of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution and related services. The Healthcare Network segment includes activities for pathology, food processing and marketing of healthcare and over the counter (OTC) products through e-commerce portals, such as www. sastasundar.com, www. retailershakti.com and diagnostic services, which consist of pathological / radiological investigations. The company provides solutions to a range of healthcare needs from preventive care to diagnostics to medicine procurement to doctor consultation. DNAVITA is its health supplement and YANA Diet Clinic is its online diet clinic.
Contact
IPO
Employees
Officers
The intrinsic value of one
SASTASUNDR
stock under the Base Case scenario is
178.05
INR.
Compared to the current market price of 303 INR,
Sastasundar Ventures Ltd
is
Overvalued by 41%.
You don't have any saved screeners yet
